Efficacy and safety of dupilumab in patients with moderate-to-severe atopic dermatitis and comorbid allergic rhinitis
Dupilumab treatment resulted in clinically relevant improvements in symptoms of AD and AR and had an acceptable safety profile.
Authors
- Gongsheng Yuan (ORCID: https://orcid.org/0000-0002-5897-0064)
- Y L Li
- Wei Jiang (ORCID: https://orcid.org/0000-0001-7615-0900)
- Tengfei Tian (ORCID: https://orcid.org/0000-0002-8029-3418)
Institutions
- Second Hospital of Shandong University (CN)
- Zhongda Hospital Southeast University (CN)
- Eye & ENT Hospital of Fudan University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fmed.2025.1556769
- Citations
- 4
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 8.02